Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

LATEST NEWS

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions

Honoring World Blood Donor Day 2022

Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado

Terumo Blood and Cell Technologies Receives $10.6M Contract From U.S. Government to Continue Freeze-Dried Plasma Development

Antoinette Gawin is the only female and non-Japanese member in an important new Terumo Corporation GMEO role.

Terumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development

Queen’s University Belfast and Terumo Blood and Cell Technologies collaborate in Knowledge Transfer Partnership to develop next generation pharmaceutical packaging

U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}